Armistice Capital’s Avanos Medical AVNS Stock Holding History

Armistice Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28M	Sell	2,000,000 -1,200,000	-38%	-$16.2M	0.5%	34
2025 Q4	$35.9M	Buy	3,200,000 +700,000	+28%	+$8.01M	0.43%	39
2025 Q3	$28.9M	Buy	2,500,000 +464,000	+23%	+$5.43M	0.43%	35
2025 Q2	$24.9M	Buy	2,036,000 +36,000	+2%	+$453K	0.43%	34
2025 Q1	$28.7M	Buy	+2,000,000	New	+$31.2M	0.43%	48
2021 Q1	–	Sell	-156,000	Closed	-$7.16M	–	112
2020 Q4	$7.16M	Sell	156,000 -41,000	-21%	-$1.71M	0.24%	74
2020 Q3	$6.54M	Buy	+197,000	New	+$6.3M	0.24%	73

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Armistice Capital's AVNS Position: Q1 2026 in Review

Armistice Capital reduced its Avanos Medical (AVNS) stake by 38% in Q1 2026, selling an estimated $16.2M and leaving 2,000,000 shares worth $28M. The position accounts for 0.5% of the portfolio, ranked #34.

Armistice Capital first reported a position in AVNS in Q3 2020 and has held it in 7 quarters since. The position peaked at $35.9M in Q4 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Armistice Capital held 2,000,000 shares of Avanos Medical worth $28M as of Q1 2026.
Armistice Capital sold 1,200,000 Avanos Medical shares in Q1 2026, an estimated $16.2M.
Avanos Medical made up 0.5% of Armistice Capital's portfolio in Q1 2026, its #34 holding.
Armistice Capital first reported a position in Avanos Medical in Q3 2020 and has held it in 7 quarters since.
Armistice Capital's Avanos Medical position peaked at $35.9M in Q4 2025.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.